Zen Technologies shares fall 10% after weak Q1 FY27 earnings
Synopsis
Key Takeaways
Shares of Zen Technologies Ltd. tumbled more than 10 per cent in early trade on Monday, 27 July, after the defence technology firm posted a sharply weaker set of results for the first quarter of FY27, dragged by lower revenue and a steep compression in operating margins. The stock hit an intraday low of ₹1,585.55 on the BSE before recovering partially to trade at ₹1,688.95, still down 4.55 per cent, as of around 10:50 am IST.
Key Financial Figures
Revenue from operations fell 10.5 per cent year-on-year to ₹142 crore in the April–June 2025 quarter, compared with ₹158 crore in the corresponding period of the previous fiscal. The decline, though modest in absolute terms, was amplified at the operating level.
EBITDA contracted 38.8 per cent to ₹38.7 crore from ₹63.3 crore a year earlier, while the EBITDA margin narrowed sharply to 27.3 per cent from 40 per cent — a contraction of nearly 13 percentage points in a single year. Net profit dropped 27.8 per cent to ₹34.5 crore, against ₹47.8 crore in the year-ago quarter. The company also reported a one-time loss of ₹3.4 crore that further weighed on the bottom line.
Why Margins Collapsed
The disproportionate fall in EBITDA relative to revenue points to a meaningful rise in operating costs — a pattern that often emerges in defence-tech firms when project execution timelines slip or high-margin contracts are delayed into subsequent quarters. Notably, Zen Technologies derives a significant share of its revenue from simulation and training systems for the Indian armed forces, a segment where order execution can be lumpy and quarter-to-quarter volatility is common.
This is not the first time the company has faced a soft quarter; however, the scale of margin compression in Q1 FY27 is among the steepest in recent reporting periods, making the management's commentary on order book health particularly critical for investors.
Board Approves QIP Deadline Extension
Separately, the board of Zen Technologies approved a two-year extension for the utilisation of proceeds raised through its qualified institutional placement (QIP) conducted in August 2024. The company has been filing regular monitoring and deviation reports with stock exchanges on the deployment of those funds. The extension signals that the originally planned capital expenditure or investment timelines have been pushed out, which could raise questions among institutional investors about execution pace.
Stock Performance and Outlook
At its intraday low of ₹1,585.55 on Monday, the stock was trading closer to its 52-week low of ₹1,224 than its 52-week high of ₹2,023.40 on the BSE, reflecting the erosion of the premium investors had assigned to the counter. The disappointing quarterly performance has now shifted market focus to the company's order pipeline and management guidance for the remainder of FY27. A recovery in margins in the coming quarters will be key to restoring investor confidence in the stock.